Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Inflammatory bowel disease has no borders: engaging patients as partners to deliver global, equitable and holistic health care.
Overview to Challenges in IBD 2024-2029.
The Role of Biosimilars in Inflammatory Bowel Disease.
Vedolizumab for perianal fistulizing Crohn's disease: systematic review and meta-analysis.
We once were blind and now we see: is it time to treat ulcerative colitis to achieve mucosal healing?
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Vedolizumab for perianal fistulizing Crohn's disease: systematic review and meta-analysis.
Vedolizumab for perianal fistulizing Crohn's disease: systematic review and meta-analysis. Intest Res. 2022 Apr; 20(2):240-250.
View in:
PubMed
authors with profiles
David Rubin
Russell Cohen
Sushila Dalal
Joel Pekow
Dejan Micic
Matthew Odenwald